Impact of informed consent quality on illness uncertainty among patients with cancer in clinical trials: A cross-sectional study
Enhancing the quality of informed consent can effectively reduce illness uncertainty among patients with cancer in clinical trials. Greater emphasis should be placed on clear communication of risks and discomforts and patient-centered interventions to mitigate psychological stress.
Authors
- Hong Yang (ORCID: https://orcid.org/0000-0001-8112-4248)
- Yuhan Lu (ORCID: https://orcid.org/0000-0003-3752-8354)
- Jie Zhang (ORCID: https://orcid.org/0000-0001-7821-4808)
- Dong Pang (ORCID: https://orcid.org/0000-0002-0448-9128)
- Xiaohong Liu (ORCID: https://orcid.org/0000-0002-6803-5846)
- Renxiu Guo
- Shan Kang (ORCID: https://orcid.org/0000-0001-7790-2393)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ministry of Education (ET)
Publication Details
- Journal
- Asia-Pacific Journal of Oncology Nursing
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.apjon.2025.100673
- Citations
- 1
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88